Manchester University Nhs Foundation Trust
Manchester M23 9QZ
11 studies enrolling now · 34 studies all time
What they study most
ADPKD, Achondroplasia, Acute Coronary Syndrome, Acute Gastroenteritis, Acute Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Acute Myocardial Infarction, Alport Syndrome, Autosomal Dominant Polycystic Kidney, Breast Cancer, Liquid Biopsy, Early Detection, COVID-19
Studies at this site
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease — Recruiting now
- A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Recruiting now
- Study of WAL0921 in Patients With Glomerular Kidney Diseases — Recruiting now
- Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH) — Recruiting now
- A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants — Recruiting now
- Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients — Recruiting now
- Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE) — Recruiting now
- Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases — Recruiting now
- Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening — Recruiting now
- Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease — Recruiting now
- Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism — Completed
- Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial — Starting soon
- A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis — Running, not enrolling
- A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD) — Completed
- A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome — Running, not enrolling
- Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS — Running, not enrolling
- A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis — Running, not enrolling
- A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 — Completed
- A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis — Running, not enrolling
- Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS — Completed
- Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome — Completed
- A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease — Completed
- CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
- A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age — Completed
- Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma — Stopped early
- A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON — Stopped early
- Adalimumab in JIA-associated Uveitis Stopping Trial — Completed
- Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism — Completed
- A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome — Completed
- Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
- A Safety and Efficacy Study of LYS-GM101 Gene Therapy in Patients With GM1 Gangliosidosis — Stopped early
- An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis — Stopped early
- Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment — Completed
- Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) — Completed